Richard Anderson
Stock Analyst at Wedbush
(3.60)
# 742
Out of 4,839 analysts
140
Total ratings
56.16%
Success rate
4.12%
Average return
Main Sectors:
Stocks Rated by Richard Anderson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HR Healthcare Realty Trust | Maintains: Neutral | $18 → $16 | $14.33 | +11.65% | 9 | May 5, 2025 | |
| DOC Healthpeak Properties | Maintains: Outperform | $24 → $22 | $16.82 | +30.80% | 5 | Apr 28, 2025 | |
| SAFE Safehold | Reiterates: Neutral | $20 | $14.52 | +37.74% | 5 | Apr 1, 2025 | |
| NHI National Health Investors | Reiterates: Outperform | $88 | $72.14 | +21.99% | 4 | Mar 17, 2025 | |
| CTRE CareTrust REIT | Reiterates: Underperform | $26 | $28.32 | -8.19% | 3 | Mar 14, 2025 | |
| STRW Strawberry Fields REIT | Maintains: Outperform | $12 → $14 | $9.88 | +41.70% | 2 | Mar 5, 2025 | |
| VTR Ventas | Maintains: Outperform | $69 → $78 | $63.65 | +22.55% | 7 | Feb 14, 2025 | |
| WELL Welltower | Upgrades: Outperform | $145 → $167 | $146.90 | +13.68% | 5 | Feb 14, 2025 | |
| UMH UMH Properties | Reiterates: Neutral | $20 | $16.38 | +22.10% | 4 | Jan 13, 2025 | |
| DEI Douglas Emmett | Upgrades: Outperform | $19 → $21 | $14.11 | +48.83% | 2 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $81 → $70 | $64.63 | +8.31% | 5 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $34 → $33 | $31.20 | +5.77% | 3 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $72 | $61.38 | +17.30% | 1 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $110 | $68.61 | +60.33% | 7 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $209 | $165.99 | +25.91% | 5 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $40 | $34.85 | +14.78% | 3 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $118 → $131 | $114.40 | +14.51% | 4 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $68 → $75 | $68.30 | +9.81% | 5 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $264 → $301 | $273.76 | +9.95% | 8 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $49 | $40.10 | +22.19% | 4 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $44 → $45 | $34.27 | +31.31% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $33 | $26.98 | +22.31% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $154 → $184 | $154.41 | +19.16% | 4 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $22 | $14.83 | +48.35% | 2 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $17 | $10.26 | +65.69% | 3 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $51 | $46.03 | +10.80% | 2 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $59 → $49 | $48.48 | +1.07% | 5 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $34.54 | +30.28% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $67 | $55.56 | +20.59% | 2 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $11 → $7.5 | $1.92 | +290.63% | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $94 | $95.37 | -1.44% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $14 | $9.07 | +54.36% | 2 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $17.09 | -6.38% | 5 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $34 | $36.00 | -5.56% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $179 | $199.86 | -10.44% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $5.73 | - | 2 | May 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $7.84 | - | 5 | Nov 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $4.15 | - | 2 | Jul 10, 2017 |
Healthcare Realty Trust
May 5, 2025
Maintains: Neutral
Price Target: $18 → $16
Current: $14.33
Upside: +11.65%
Healthpeak Properties
Apr 28, 2025
Maintains: Outperform
Price Target: $24 → $22
Current: $16.82
Upside: +30.80%
Safehold
Apr 1, 2025
Reiterates: Neutral
Price Target: $20
Current: $14.52
Upside: +37.74%
National Health Investors
Mar 17, 2025
Reiterates: Outperform
Price Target: $88
Current: $72.14
Upside: +21.99%
CareTrust REIT
Mar 14, 2025
Reiterates: Underperform
Price Target: $26
Current: $28.32
Upside: -8.19%
Strawberry Fields REIT
Mar 5, 2025
Maintains: Outperform
Price Target: $12 → $14
Current: $9.88
Upside: +41.70%
Ventas
Feb 14, 2025
Maintains: Outperform
Price Target: $69 → $78
Current: $63.65
Upside: +22.55%
Welltower
Feb 14, 2025
Upgrades: Outperform
Price Target: $145 → $167
Current: $146.90
Upside: +13.68%
UMH Properties
Jan 13, 2025
Reiterates: Neutral
Price Target: $20
Current: $16.38
Upside: +22.10%
Douglas Emmett
Jan 2, 2025
Upgrades: Outperform
Price Target: $19 → $21
Current: $14.11
Upside: +48.83%
Jan 2, 2025
Downgrades: Underperform
Price Target: $81 → $70
Current: $64.63
Upside: +8.31%
Jan 2, 2025
Upgrades: Outperform
Price Target: $34 → $33
Current: $31.20
Upside: +5.77%
Dec 17, 2024
Initiates: Neutral
Price Target: $72
Current: $61.38
Upside: +17.30%
Dec 6, 2024
Maintains: Neutral
Price Target: $120 → $110
Current: $68.61
Upside: +60.33%
Oct 25, 2024
Reiterates: Outperform
Price Target: $209
Current: $165.99
Upside: +25.91%
Sep 20, 2024
Reiterates: Outperform
Price Target: $40
Current: $34.85
Upside: +14.78%
Aug 5, 2024
Maintains: Outperform
Price Target: $118 → $131
Current: $114.40
Upside: +14.51%
Aug 5, 2024
Maintains: Neutral
Price Target: $68 → $75
Current: $68.30
Upside: +9.81%
Aug 5, 2024
Maintains: Neutral
Price Target: $264 → $301
Current: $273.76
Upside: +9.95%
Aug 5, 2024
Maintains: Outperform
Price Target: $45 → $49
Current: $40.10
Upside: +22.19%
Aug 5, 2024
Maintains: Outperform
Price Target: $44 → $45
Current: $34.27
Upside: +31.31%
Aug 5, 2024
Maintains: Outperform
Price Target: $28 → $33
Current: $26.98
Upside: +22.31%
Aug 5, 2024
Maintains: Outperform
Price Target: $154 → $184
Current: $154.41
Upside: +19.16%
May 30, 2024
Reiterates: Outperform
Price Target: $22
Current: $14.83
Upside: +48.35%
May 28, 2024
Reiterates: Neutral
Price Target: $17
Current: $10.26
Upside: +65.69%
May 17, 2024
Reiterates: Outperform
Price Target: $51
Current: $46.03
Upside: +10.80%
Apr 25, 2024
Downgrades: Neutral
Price Target: $59 → $49
Current: $48.48
Upside: +1.07%
Apr 22, 2024
Initiates: Neutral
Price Target: $45
Current: $34.54
Upside: +30.28%
Mar 28, 2024
Reiterates: Neutral
Price Target: $67
Current: $55.56
Upside: +20.59%
Feb 20, 2024
Downgrades: Neutral
Price Target: $11 → $7.5
Current: $1.92
Upside: +290.63%
Oct 3, 2023
Initiates: Outperform
Price Target: $94
Current: $95.37
Upside: -1.44%
Oct 3, 2023
Initiates: Neutral
Price Target: $14
Current: $9.07
Upside: +54.36%
Oct 3, 2023
Initiates: Outperform
Price Target: $16
Current: $17.09
Upside: -6.38%
Oct 3, 2023
Initiates: Neutral
Price Target: $34
Current: $36.00
Upside: -5.56%
Oct 3, 2023
Initiates: Neutral
Price Target: $179
Current: $199.86
Upside: -10.44%
May 7, 2018
Upgrades: Neutral
Price Target: n/a
Current: $5.73
Upside: -
Nov 6, 2017
Upgrades: Neutral
Price Target: n/a
Current: $7.84
Upside: -
Jul 10, 2017
Upgrades: Buy
Price Target: n/a
Current: $4.15
Upside: -